Analyzing Possible Industry Implications Of FDA Advisory Panel Decision On MDMA
Analyzing Possible Industry Implications Of FDA Advisory Panel Decision On MDMA . (MENAFN - Investor Brand Network) 

About a week ago, an advisory committee to the U.S. Food and Drug Administration (FDA)rejected evidence supporting the approval of MDMA as an alternative ...
América - MenaFN
(MENAFN- Investor Brand Network) About a week ago, an advisory committee to the U.S. Food and Drug Administration (FDA)

rejected evidence supporting

the approval of MDMA as an alternative for post-traumatic stress disorder (PTSD). This is a deflating moment for many in psychedelic research who have, for years, conducted trials on the drug in an effort to gain approval for commercial distribution.

The application reviewed by the advisory committee was presented by Lykos Therapeutics , which concluded phase 2 and 3 trials investigating the...

Read More>>

About PsychedelicNewsWire

PsychedelicNewsWire

(“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within

the

Dynamic Brand Portfolio

@

IBN

that delivers :

(1) access to a vast network of wire solutions via

InvestorWire

to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;

(2) article and

editorial syndication to 5,000+ outlets ;

(3) enhanced

press release enhancement

to ensure maximum impact ;

(4)

social media distribution

via IBN to millions of social media followers ;

and (5) a full array of tailored

corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text“Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit



Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

/Disclaimer

PsychedelicNewsWire

San Francisco, CA



415.949.5050 Office

[email protected]

PsychedelicNewsWire is powered by

IBN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108864810/Analyzing-Possible-Industry-Implications-Of-FDA-Advisory-Panel-Decision-On-MDMA
2024-11-08
rss
(MENAFN - Investor Brand Network) 

About a week ago, an advisory committee to the U.S. Food and Drug Administration (FDA)rejected evidence supporting the approval of MDMA as an alternative ...
Analyzing Possible Industry Implications Of FDA Advisory Panel Decision On MDMA